Skip to main content
TipRanks
Go Ultimate75% OFF

HOYA (HYB0) AI Stock Analysis

1 Followers
DE:HYB0

HOYA

(Frankfurt:HYB0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Exceptional ProfitabilityHOYA’s unusually strong gross, operating, and net margins indicate differentiated products, pricing power, and efficient operations across its optical, healthcare, and precision-technology businesses. This profitability provides durable funding for innovation and helps protect earnings through moderate demand changes.
Negative Factors
Slowing Revenue GrowthRecent top-line deceleration could constrain future earnings expansion if HOYA cannot offset slower volume growth through new products, market gains, or pricing. With margins already high, further profit growth may increasingly depend on restoring stronger revenue momentum rather than efficiency gains.

HOYA (HYB0) vs. iShares MSCI Germany ETF (EWG)

-5%0%5%10%15%20%25%30%DE:HYB0+4.45%EWG+1.23%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 47.10B
Dividend Yield
1.33%
Average Volume (3M)
45
Price to Earnings (P/E)
27.2
Beta (1Y)
0.82
Revenue Growth
1.85%
EPS Growth
24.77%
Country
Germany
Employees
37,752
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

HOYA Business Overview & Revenue Model

Company Description

Globally recognized as a med-tech innovator, HOYA Corporation is a prominent provider of advanced technology and healthcare solutions worldwide. Its comprehensive portfolio of life care products encompasses vision correction items such as eyeglasses...

HOYA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:HYB0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ISRGISRG85Outperform$141.17B47.7317.03%―20.45%8.75%
BLCOBLCO65Neutral$7.40B-62.58-1.73%―8.88%63.73%
BDXBDX63Neutral$57.93B51.274.64%1.87%-7.40%-28.89%
STAASTAA59Neutral$1.26B2422.000.15%―42.36%―
COOCOO54Neutral$11.47B20.096.88%―4.73%43.89%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-40%-20%0%20%40%DE:HYB0BDXCOOISRGSTAABLCODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:HYB0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:HYB0Hoya Corp132.006.625.28%
BDXBecton, Dickinson and Co212.7866.3845.34%
COOCooper Companies58.88-17.13-22.54%
ISRGIntuitive Surgical399.05-169.43-29.80%
STAAStaar Surgical Company24.22-2.32-8.74%
BLCOBausch + Lomb Corporation19.383.9325.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.